Item 2.02. Results of Operations and Financial Condition.
On May 10, 2022, Recursion Pharmaceuticals, Inc. issued a press release
announcing its results of operations and financial condition for the first
quarter March 31, 2022. A copy of the press release is furnished as Exhibit 99.1
and is incorporated herein by reference.
Item 7.01. Regulation FD Disclosure.
On May 10, 2022, Recursion Pharmaceuticals, Inc. released an updated investor
presentation. The investor presentation will be used from time to time in
meetings with investors. A copy of the presentation is attached hereto as
The information furnished pursuant to Item 2.02 (including Exhibit 99.1) and
7.01 (including Exhibit 99.2) on this Form 8-K, shall not be deemed "filed" for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), or otherwise subject to the liabilities of that section, nor
shall it be deemed incorporated by reference into any other filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as expressly set
forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
Exhibit Number Description
Press release issued by Recursion Pharmaceuticals, Inc. dated May
99.1 10 , 202 2
Investor presentation of Recursion Pharmaceuticals, Inc. dated May 10,
Cover Page Interactive Data File (embedded within the Inline XBRL
© Edgar Online, source Glimpses